双双白蛋白受体对抗性减少了在戒断期间寻求氧化的需求
bioRxiv : the preprint server for biology
|April 16, 2025
概括
作为克莱受体对抗剂的苏沃雷克桑 (suvorexant) 显著降低了在戒断的个体中寻求氧化的需求. 这种药物使多巴胺功能正常化,这表明一种新的非阿片类药物治疗阿片类药物使用障碍和渴望.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 成 药物 药物 药物 药物
背景情况:
- 阿片类药物使用障碍 (OUD) 治疗面临的挑战在戒断期间持续的渴望.
- 目前对OUD的药物治疗主要是基于阿片类药物,突出显示了对新型非阿片类药物替代品的需求.
- 低素/素系统通过多巴胺通路调节对滥用药物的动机,使其成为潜在的治疗目标.
研究的目的:
- 为了评估二重曲素受体对抗剂suvorexant在减少戒断期间寻求氧化的疗效.
- 调查suvorexant恢复多巴胺传输异常与氧化使用相关的能力.
主要方法:
- 在临床前研究中使用了间歇性访问 (IntA) 氧化模型.
- 评估暗示诱导的氧化寻求14天的戒断期后.
- 测量的多巴胺吸收在核 accumbens 核心后,suvorexant 管理.
主要成果:
- 氧化诱导的IntA对氧化诱导的持续的暗示诱导的氧化寻找和减少核中多巴胺的吸收.
- 苏弗雷克桑治疗显著减弱了暗示诱导的氧化寻找.
- 苏沃雷克桑特的使用使核本核中观察到的异常多巴胺吸收正常化.
结论:
- 用suvorexant准克雷丁受体显示出减少阿片类药物渴望和复发的承诺.
- 苏沃雷克桑有效地减少了寻找药物的行为,并在戒氧期间恢复了多巴胺功能.
- 这些发现支持开发克列受体对抗剂作为阿片类药物使用障碍的非阿片类药物疗法.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
173
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
173
Opioid Receptors: Overview
332
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
332
Analgesia and Pain Management
399
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
399
Drug Abuse and Addiction: Pharmacological Phenomena
410
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
410
Drug Dependence
950
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
950
Drug-Receptor Interaction: Agonist
2.3K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.3K


